Pet Care and Veterinary Clinic Chain Risk Profile in India 2026: Veterinary PI, Premises Liability and Animal Custody Exposure

Indian pet ownership has crossed an estimated 35 million urban households by 2026, with the dog population alone exceeding 31 million and cat ownership rising rapidly from a low base. The expansion has been driven by a generational shift in middle-class household behaviour through 2020-25, with urban millennials and Gen Z households treating pet ownership as a primary identity and lifestyle choice rather than a peripheral activity. The economic implications have produced an entire pet care economy spanning veterinary services, food and nutrition products, grooming, boarding, training, walking and pet-tech, with the Federation of Indian Animal Protection Organisations (FIAPO) and industry trackers estimating organised market value at INR 12,000 to 16,000 crore by FY2025-26 and projecting strong growth through FY2026-27 and FY2027-28.

The veterinary services component, historically dominated by single-practice clinics operated by individual veterinarians, has seen rapid corporatisation through 2022-26. Branded chain operators including CGS Hospital (Mumbai), Cessna Lifeline Veterinary Hospital (Bengaluru), Crown Vets (Mumbai), Pawsh (Delhi-NCR), ZiglyVet (multi-city), DCC Animal Hospital (Delhi), Max Vets (Delhi-NCR) and Pet Practice India have built multi-site footprints with standardised clinical protocols, diagnostic imaging capability, surgical theatres, in-patient care and 24x7 emergency operations. The parallel product ecosystem has been built by Heads Up For Tails (HUFT), Supertails, Wiggles, Mars Petcare India, Drools, Bark Out Loud and others, providing pet food, accessories, and increasingly veterinary-aligned health products distributed through retail, ecommerce and clinic channels.

Despite the market scale, the insurance underwriting for pet care chains in India remains underdeveloped relative to comparable segments in the United Kingdom, Australia, and Singapore. The 2026 underwriting gap arises from four structural factors. First, the historical claims experience pool is thin because few chain operators existed before 2020; insurers lack the loss data to price professional indemnity, animal custody, and premises liability covers with confidence. Second, the Veterinary Council of India (VCI) governance framework, while regulating veterinary qualification and registration, has not produced standardised quality benchmarks that insurers can use to differentiate operator risk. Third, animal custody claims and veterinary professional indemnity claims are processed through general courts rather than dedicated tribunals, producing uncertain liability quanta and protracted disputes. Fourth, the typical commercial broker engagement has historically not extended to pet care operators because the premium scale per location is small (INR 2 to 8 lakh annually for a standalone clinic) and the broker economics do not support deep engagement.

The 2026 underwriting environment is shifting. The chain operators have reached scale where corporate risk management is a board-level function, with consolidated programmes across multiple locations producing premium scale that supports broker engagement. ICICI Lombard, HDFC Ergo, TATA AIG, Bajaj Allianz and Future Generali are all developing specific pet care underwriting capability with named portfolio managers. Foreign reinsurer interest has emerged with Munich Re and Hannover Re evaluating the segment for product-liability and professional-indemnity capacity. Specialty broker engagement has begun, with broker firms previously focused on healthcare and life sciences extending into pet care chains as the corporate sophistication has grown.

For brokers and risk managers, the pet care chain segment in 2026 sits in an interesting position: large enough to require professional insurance advisory, structurally different from human healthcare in regulatory and clinical respects, and underserved by the existing commercial broker market. This post examines the underwriting risk profile of Indian veterinary chain operators, the specific cover heads required, the regulatory and operational pressure points, and the broker playbook for engaging the segment.

Veterinary professional indemnity in India is structurally distinct from medical professional indemnity in three respects that materially affect underwriting. First, the patient is an animal owned by a human client, creating a triangular relationship where the duty of care is owed primarily to the client (the animal owner) and the contractual relationship is with the client, even though the clinical work is performed on the animal. Second, animal life is not legally equivalent to human life under Indian law, producing materially different quanta in negligence claims that succeed; courts have produced damages awards in animal injury cases that range from INR 50,000 to INR 25 lakh in reported decisions, with sentimental value and loss of companionship recognised but not at quanta comparable to human personal injury. Third, the regulatory framework under the Indian Veterinary Council Act, 1984 and the Veterinary Practitioners Regulations produces a more limited regulatory enforcement environment than the medical equivalent under the National Medical Commission framework.

The clinical risk profile across Indian veterinary chains in 2026 spans recognisable patterns. Anaesthetic events during routine surgery (neutering, spaying, dental extractions, soft-tissue surgery) represent the highest-frequency clinical loss category. Indian veterinary practice has rapidly adopted modern anaesthetic protocols including isoflurane and sevoflurane gas anaesthesia, balanced anaesthetic regimens, and intra-operative monitoring including pulse oximetry, capnography and ECG. However, the practitioner training distribution across the country remains uneven, with senior surgeons at chain operators typically holding advanced training but support staff in some locations holding more limited qualifications. Anaesthetic mortality at well-equipped chain operators sits in the 0.05% to 0.2% range for healthy patients, rising materially for elderly or chronically ill patients; the absolute number of events across a large chain produces a steady flow of professional indemnity claims.

Misdiagnosis and missed-diagnosis events form the second high-frequency category. Common patterns include missed pyometra (uterine infection in unspayed females presenting with non-specific signs), missed gastric dilatation-volvulus in large breeds presenting in early stages, undiagnosed cardiac disease that produces sudden death during routine procedures, and missed neoplasia where early intervention would have changed outcome. Diagnostic imaging capability (digital radiography, ultrasound, advanced CT increasingly available at premium chain operators) has improved detection materially, but interpretation expertise varies across the practitioner population and produces residual missed-diagnosis exposure.

Medication and prescribing errors are a third category. Common patterns include dose calculation errors in small breeds where weight-based dosing produces narrow therapeutic windows, NSAID administration in patients with undisclosed renal or hepatic compromise, and drug interaction events. The chain operator environment with electronic prescribing systems and pharmacist support has reduced error frequency, but events continue and produce claims where animal harm is demonstrable.

Surgical complications including wound dehiscence, retained surgical material, post-operative infection and unintended structural damage during procedures form the fourth category. The chain operator surgical environment with dedicated surgical theatres, sterile protocols and post-operative monitoring has reduced complication rates relative to mobile or non-specialist practice, but events occur and produce claims where complication management is alleged to have been inadequate.

The veterinary professional indemnity insurance market in India 2026 typically prices at INR 1.5 to 4 lakh per qualified veterinarian for INR 1 to 5 crore per claim with INR 2 to 10 crore aggregate cover, with rates varying by procedure mix, claim history, and operator scale. The cover responds to claims arising from the insured veterinarian's professional acts and omissions, with typical exclusions for criminal acts, intentional harm, drug abuse by the practitioner, and acts outside scope of qualification. Chain operators benefit from blanket cover structures where all employed veterinarians are covered under a single programme; the per-veterinarian cost is materially lower than individual placement and the cover scope can be aligned across the chain.

The defence cost component is particularly significant in the Indian environment. Veterinary professional indemnity claims often involve extended dispute periods (24 to 60 months from event to resolution) with material expert witness, legal counsel, and documentation costs. Cover wordings that include defence costs within the per-claim limit produce material cover erosion in defended claims; cover wordings that include defence costs outside the limit (defence costs in addition to indemnity) preserve more economic protection for chain operators facing multiple defended claims. Brokers placing pet care chain PI cover should specifically negotiate defence cost positioning and document the position for the operator client.

Animal custody exposure arises whenever an animal is in the chain operator's care and produces specific underwriting risk distinct from professional indemnity. The custody periods at a veterinary chain span surgical inpatient stays, post-operative observation, boarding services attached to the clinic, and longer-term care for chronically ill or behaviourally challenging patients whose owners are temporarily unable to provide care. The custody risk includes escape, fighting with other animals in the facility, accidental injury during handling, theft, fire and natural perils affecting the facility, and conditions developing during the custody period (heat stress in summer, hypothermia in winter, dehydration or feeding-related complications).

The legal characterisation of animal custody under Indian law treats the operator as a bailee with duties of reasonable care; the standard is not strict liability but the operator must demonstrate that the care provided met reasonable veterinary standards. Court decisions on animal custody losses have generally followed three patterns. First, where the operator's negligence is demonstrable, damages awards have included replacement value of the animal, medical costs incurred for treatment, and (in some cases) sentimental value awards typically in the INR 1 to 10 lakh range. Second, where the operator's care met reasonable standards but loss occurred from intrinsic patient condition or unforeseen events, courts have generally not awarded damages. Third, where the operator's documentation of care is inadequate or where consent processes were not properly followed, courts have inferred negligence and awarded damages.

The pet animal custody insurance product in the Indian market is structured under public liability extensions or under specific custody endorsements on the chain operator's combined programme. Cover typically responds to claims by animal owners for injury, death or condition of the animal arising from operator custody, with sub-limits typically at INR 5 to 25 lakh per animal and INR 1 to 5 crore aggregate. Exclusions typically include pre-existing conditions not disclosed at admission, conditions arising from underlying disease processes not caused by operator action, and consequential losses claimed by the owner beyond direct animal-related damages.

The boarding service component, increasingly offered by chain operators as a revenue diversification, presents a different risk profile. Boarding animals are typically healthy and the custody period extends from days to weeks. The boarding risk concentrates on escape (including escape from outdoor exercise areas), fighting between animals (particularly where group housing is used), theft (including by employees), heat and cold stress (particularly during extended stays), and operator non-care events (feeding lapses, water provision lapses, medication administration lapses). Boarding facility custody losses have produced increasing claims activity through 2024-26 as the segment has scaled, with chain operators offering boarding alongside clinical services facing combined-programme claims that mix clinical and custody factors.

The surgical inpatient component requires specific attention to consent processes. The Indian veterinary practice norm is informed consent from the animal owner before procedures, including disclosure of anaesthetic risk, alternative treatment options, and expected costs. Chain operators with documented consent processes that include signature on consent forms, recorded discussion of risk, and post-procedure communication of outcome have substantially reduced their exposure on consent-based claims. Operators with weaker documentation face increased claims activity where outcomes are adverse and where owners allege that risks were not properly disclosed.

The General Insurance Corporation of India (GIC Re) treaty backing for pet care segment cover has been thin historically, with most cover supported by primary insurers retaining the bulk of the risk. Foreign reinsurer engagement is emerging, with Munich Re and Hannover Re evaluating the segment for specialty product-liability and professional-indemnity capacity. Brokers serving chain operators should monitor reinsurance capacity developments because cover scope expansion is often constrained by reinsurance support rather than primary insurer appetite.

For chain operators, the operational risk management investments that materially reduce custody exposure include video surveillance of kennel and ICU areas, electronic medication administration records with timestamped entries, temperature monitoring in inpatient and boarding areas, escape-prevention infrastructure including double-gated entry to outdoor areas, and structured handover protocols when animals transfer between care shifts. Insurers underwriting chain operator programmes increasingly evaluate these controls in pricing decisions, with operators demonstrating documented investment receiving more favourable terms.

Premises liability at a veterinary chain operator presents the standard commercial liability profile of any consumer-facing healthcare facility, with three specific accentuations. First, the visitor population includes the animal owner and their family members who are not the primary patient and whose interaction with the facility is more peripheral than at a human healthcare facility; this produces a less predictable visitor behaviour pattern. Second, animals (the patients) interact with the visitor population in ways that produce specific bite, scratch and infection-transmission risks. Third, the multi-site operator footprint, often combining freehold facilities, leased premises and franchise-operated locations, produces uneven risk control across the chain and insurance coordination complexity.

The bite and scratch exposure is the most distinctive premises liability accentuation. Animals brought to a veterinary facility are often stressed, injured, ill, or in unfamiliar surroundings, and behavioural reactions including biting and scratching of staff, other animals, and visitors are foreseeable risks. The chain operator's exposure spans three populations. Staff bite injuries are typically processed through employee compensation arrangements and are not the primary insurance question. Animal-on-animal bites in waiting areas, examination rooms and treatment areas produce animal injury claims that flow through custody insurance. Visitor bites by another client's animal produce premises liability claims where the operator's reasonable supervision is the defensibility question.

Indian courts have produced limited reported decisions on animal-bite premises liability against veterinary operators specifically, but the broader case law on premises liability for animal-related injuries (most extensively in residential and commercial property contexts) suggests that the operator's duty includes maintaining segregation between unfamiliar animals, providing appropriate examination room privacy, ensuring leash and restraint protocols are followed in waiting areas, and warning visitors of foreseeable risks. Chain operators with documented visitor management policies, leash-required signage, separate cat and dog waiting areas, and structured intake protocols have demonstrated lower claims activity than operators without these controls.

Slip-and-fall exposure follows the general commercial premises pattern but with specific accentuation around floor cleaning protocols (cleaning frequency in clinical areas produces wet floor exposure), wash-down areas (drainage and grip control affect employee and visitor safety), and outdoor areas (rainwater and animal waste create slip risks). The chain operator population is typically well-controlled on these factors, but documentation of cleaning schedules, maintenance protocols and incident response is essential for claims defence.

Food service exposure arises at chain operators offering retail food sales or in-clinic food preparation for inpatients. The exposure spans food contamination causing animal illness, allergic reactions to ingredients not adequately disclosed, and (rarely) human food preparation in waiting areas. The insurance response is through product liability cover on the retail food component and through general premises liability on the in-clinic preparation; the exposure is small at most chain operators but should be documented in the programme structure.

Multi-site operator structures produce specific coordination questions. Where the chain operates a combination of freehold, leased and franchise locations, the insurance programme structure must address each ownership type. Freehold locations are typically combined under a master programme with site-specific schedule additions. Leased locations require coordination with landlord insurance arrangements, particularly on building cover, public area liability and certain property heads. Franchise locations introduce the most complex structure because the franchisee is a separate legal entity with potentially different cover scope and limit decisions; the chain operator's contingent exposure for franchisee acts requires specific programme attention.

The franchise model adoption is increasing in Indian pet care chains through 2024-26 as the chains seek capital-efficient expansion. The franchise insurance question typically requires franchisees to maintain specified minimum cover levels including professional indemnity, general liability, animal custody and product liability, with the chain operator named as additional insured on franchisee programmes. The chain operator's own programme typically includes vicarious liability extension for franchise operations and brand-protection cover for events at franchise locations that produce reputational harm to the chain. Brokers advising chain operators on franchise expansion should design the insurance framework as an integrated component of the franchise agreement, not as a peripheral compliance matter.

The employee compensation exposure at chain operators includes bite injuries, anaesthetic gas exposure (particularly in surgical theatres where ventilation may be incomplete), radiation exposure at imaging facilities (with regulatory requirements under Atomic Energy Regulatory Board rules for radiation safety), needle-stick injuries, and zoonotic infection transmission. The standard employees compensation insurance under the Employees Compensation Act applies, with additional group personal accident and group health programmes typically structured for the operator workforce. Multi-site operators should standardise the employee compensation programme structure to enable consistent claims handling and clear documentation across the chain.

The pet product ecosystem in India 2026 represents a parallel insurance underwriting concern that intersects with the veterinary chain segment through clinic retail, recommended-product relationships, and increasingly through chain operator private-label product development. The major product chains in 2026 include Heads Up For Tails (HUFT) operating an India-wide retail and ecommerce footprint, Supertails as a vet-led ecommerce platform with strong subscription and consultation integration, Wiggles combining product distribution with mobile veterinary services, Drools as a food-focused brand with broad retail distribution, Mars Petcare India with Pedigree, Whiskas and prescription diet brands, Bark Out Loud in premium categories, Pawsh with combined product and grooming operations, and a long tail of regional and category-specialist brands.

The product liability exposure across this ecosystem spans recognisable risk heads. Food product contamination producing animal illness or death represents the highest-severity head, with potential for class-action style claims if a defective product reaches a wide consumer base. The 2007 melamine contamination episode in international pet food markets, while not centred on Indian product, remains a reference point for the segment's worst-case potential; subsequent contamination episodes in Indian human food supply (the 2015 Maggi episode for noodles, periodic adulteration discoveries in dairy and oil) demonstrate the regulatory and reputational dynamic that pet food contamination would attract.

Accessory product safety produces a second category. Collars, leashes, harnesses, toys, training devices and grooming products have all produced reported safety incidents in international markets, with strangulation, choking, ingestion of small parts, and chemical exposure being recurring concerns. The Indian regulatory framework for pet product safety is less developed than for human consumer goods, with no equivalent of the Bureau of Indian Standards specific pet product certification. Product liability claims for accessory defects flow through general civil court processes with the typical extended timelines.

Veterinary product safety, including over-the-counter pet health products distributed through clinic and retail channels, sits in a regulatory grey zone. Products meeting pharmaceutical thresholds require Central Drugs Standard Control Organisation (CDSCO) registration, but many products marketed for pet wellness (supplements, dental care, parasite preventives at sub-pharmaceutical concentrations) sit outside the strict registration framework. The 2024-26 trend toward stricter labelling and substance disclosure under consumer protection law has increased the documentation burden on product manufacturers and distributors, with implications for the product liability insurance position.

The ecommerce distribution model adopted by Supertails, HUFT online, and the broader pet ecommerce ecosystem produces specific liability accentuations. The platform operator's liability for products sold through the platform varies by the operator's role (marketplace facilitator versus seller of record), the contractual structure with manufacturers, and the consumer's reasonable expectations as set by the platform's marketing. Indian consumer protection law under the Consumer Protection Act, 2019 and the Consumer Protection (E-Commerce) Rules, 2020 establishes a framework that treats certain platform operators as having direct seller obligations under specified conditions. Pet product platforms should evaluate their position under this framework with legal counsel and structure product liability cover accordingly.

Product liability insurance cover for the segment in 2026 is placed through the Indian commercial insurance market with reinsurer support from foreign markets including Lloyd's syndicates. Per-claim limits typically run INR 5 to 50 crore depending on operator scale and category mix, with aggregate covers at INR 10 to 100 crore. Specific cover heads typically include third-party claims for animal injury, illness or death attributable to defective product; consumer claims for sentimental value, replacement animal costs, and direct economic loss; recall costs including notification, retrieval, replacement and disposal of defective product; and (with specific extensions) loss of profits arising from recall events.

The product recall exposure has become more material through 2024-26 as the segment scale has grown. A pet food contamination event affecting a major brand could trigger recalls running to INR 50 to 200 crore in direct costs, with consequential reputation and revenue impact materially larger. Chain operators offering private-label products face the recall exposure directly; chain operators retailing third-party products face indirect exposure through customer relationship damage if a recalled product was sold through their channel. The structured recall cover available in the Indian market is comparable to global wordings but with specific Indian distribution and supply chain considerations.

For brokers advising product chain operators, four positions are critical. First, product liability cover should specifically address pet animal injury claims with sub-limits aligned to typical and extreme claim quanta. Second, recall cover should be evaluated for the operator's specific category mix, with food and ingestible products attracting higher recall priorities. Third, ecommerce platform operators should evaluate their position under e-commerce liability frameworks and structure cover for their role as facilitator versus seller. Fourth, chain operators developing private-label products should evaluate manufacturer indemnities, contract manufacturer insurance, and product testing protocols as components of the integrated liability programme.

The regulatory framework affecting pet care chains in 2026 spans four primary bodies with distinct authority scopes. The Veterinary Council of India (VCI) regulates veterinary practice including practitioner qualification, registration, and disciplinary action under the Indian Veterinary Council Act, 1984. State Veterinary Councils operate under the VCI umbrella with primary registration and enforcement authority within their states. The Food Safety and Standards Authority of India (FSSAI) regulates pet food and ingestible products under its general food regulation authority, with specific pet food labelling and quality standards developed through 2024-26. The Central Drugs Standard Control Organisation (CDSCO) regulates veterinary pharmaceuticals through the Drug Controller General of India, with parallel state authority. The Animal Welfare Board of India (AWBI) under the Ministry of Fisheries, Animal Husbandry and Dairying provides animal welfare oversight including standards for boarding, transport and care facilities.

The VCI framework's primary insurance implication is the registration status of practitioners. Veterinary professional indemnity cover requires the insured practitioner to hold valid VCI registration in the relevant state; cover does not respond to acts by unregistered practitioners or acts outside the scope of registration. Chain operators must maintain documented evidence of practitioner registration status, with renewal tracking and verification protocols integrated into HR and clinical governance processes. Insurer underwriting reviews increasingly request audit-quality evidence of registration management as a precondition of cover.

The FSSAI regulatory framework affects chain operators offering food retail, in-clinic food provision for inpatients and (where the chain operates a food product line) the manufacturing and distribution of food products. The FSSAI registration and licensing requirement under the Food Safety and Standards Act, 2006 applies to all food business operators including pet food, with FSSAI Pet Food Regulations notified in 2024 providing specific quality, labelling and contamination standards for the segment. Compliance with FSSAI requirements is increasingly a precondition for product liability cover on pet food lines, with insurers requiring documented FSSAI registration and audit reports.

The CDSCO framework affects veterinary pharmaceutical distribution. Veterinary pharmacy operations within chain clinics require state pharmacy licensing under the Drugs and Cosmetics Act, 1940, with additional specific veterinary product authorisations. The 2024-25 stricter enforcement of veterinary prescription drug control has tightened the operator burden, with documentation of prescriptions, controlled substance tracking, and stock audit requirements applied more rigorously than in prior years.

The AWBI framework provides animal welfare standards that increasingly influence chain operator operational design. The Prevention of Cruelty to Animals Act, 1960 and AWBI rules provide the underlying authority for welfare standards in boarding, transport, breeding and care facilities. Chain operators integrating boarding services with veterinary practice must comply with both veterinary practice standards under VCI and welfare standards under AWBI; non-compliance can produce both regulatory penalty and contractual termination of insurance cover where compliance is a coverage condition.

The pet insurance distribution question is a parallel regulatory consideration. Pet insurance for animal owners (not operator liability cover) is an emerging product category in India, with Bajaj Allianz, Future Generali, New India Assurance, and selected other insurers offering pet health and accident cover. The IRDAI has developed framework guidance for pet insurance products through 2024-26, with specific underwriting and claims standards being shaped through industry consultation. Chain operators are increasingly positioned as distribution partners for pet insurance, with corporate agent licensing or insurance marketing firm structures enabling commission income alongside the clinical business.

The insurance distribution role produces additional regulatory exposure. Chain operators acting as corporate agents under IRDAI regulations must comply with IRDAI (Registration of Corporate Agents) Regulations, 2015 as amended, including disclosure, suitability assessment, and conflict-of-interest management. Failure to comply with these regulations creates both regulatory penalty exposure and contingent customer liability for misselling or inadequate disclosure. Chain operators with documented insurance distribution operations should integrate the regulatory compliance question with the broader operator risk management programme.

[!IMPORTANT] Chain operators distributing pet insurance products to clients of their veterinary practice should specifically evaluate the conflict-of-interest position where clinical recommendations may be perceived as influenced by insurance commission earnings. Documented disclosure protocols, separation of clinical and insurance functions where practicable, and clear customer communication of the operator's dual role mitigate this exposure.

The regulatory framework as a whole is evolving rapidly through 2024-26 and into FY2026-27, with continued tightening expected across all four primary bodies. Brokers and insurers underwriting pet care chain risk should plan against continued regulatory development rather than against the static 2026 framework.

Brokers engaging with Indian pet care chain operators in 2026 face a client segment that is rapidly professionalising on the corporate side while remaining underdeveloped on the insurance underwriting side. The engagement model and programme design require attention to the segment's specific characteristics and to the multi-line cover stack that the chain operator profile requires.

The initial engagement should focus on a comprehensive operator risk profile assessment. Site visits to the chain's primary facilities, review of clinical and operational documentation, interviews with senior clinical and corporate leadership, and analysis of historical incident and claims data establish the foundation for programme design. The assessment should identify the specific risk concentrations of the operator including high-volume procedures, complex surgical work, inpatient and boarding capacity, retail and product operations, and franchise or external operator relationships.

The core programme structure for a multi-site veterinary chain in 2026 spans seven cover heads. The veterinary professional indemnity cover on a blanket structure includes all employed and contracted veterinarians with per-claim limits typically at INR 2 to 10 crore and aggregate at INR 10 to 25 crore. The animal custody cover, structured as a public liability extension or stand-alone endorsement, includes inpatient and boarding exposure with per-animal sub-limits and aggregate cover aligned to chain capacity. The public liability cover responds to visitor injury and property damage claims with per-claim limits at INR 5 to 50 crore. The product liability cover for retail and private-label operations responds to consumer claims for product-related animal injury with limits scaled to product category and distribution volume.

The fire and material damage cover on facilities including building (where freehold), contents including diagnostic and surgical equipment, and consequential business interruption typically sits at INR 5 to 30 crore per site on sums insured basis. The employees compensation and group personal accident covers respond to staff injury exposures including animal bites, anaesthetic gas exposure, and radiation exposure where applicable. The cyber liability cover responds to data exposures arising from electronic medical records, customer payment data and (increasingly) telehealth consultations.

The programme placement strategy benefits from a structured insurer engagement process. Operators with material premium spend (INR 50 lakh or higher consolidated annual premium) should engage 3 to 5 lead insurers with named portfolio managers, with broker-facilitated underwriter site visits where practical. Smaller operators may rely on a single lead insurer with simpler programme structures. Specialty cover heads (recall, regulatory liability extensions) may require specific reinsurer engagement that the broker should facilitate.

Claims advocacy and post-loss support are particularly important for chain operators because the claims volume across multiple sites produces a steady flow of professional indemnity, animal custody and premises liability events that require structured insurer engagement. Brokers serving chain operators should establish documented claims notification protocols, designated claims advocacy team contacts, and quarterly claims review meetings with insurers. The broker scorecard for chain operators specifically values claims handling depth alongside placement capability.

For FY2026-27, four trajectory questions should inform programme design. First, regulatory expansion under VCI, FSSAI, CDSCO and AWBI is expected to continue, with new compliance requirements potentially affecting both operational risk and cover availability. Second, the pet insurance distribution opportunity for chain operators is expected to expand, with corresponding regulatory exposure on the corporate agent or insurance marketing firm side. Third, foreign reinsurer engagement is expected to deepen, with potential for specialty cover expansion in professional indemnity and product liability heads. Fourth, the chain operator consolidation through M&A is expected to continue, with implications for insurance programme integration across acquired entities.

[!NOTE] Chain operators considering acquisitions of independent practices or smaller chains should integrate insurance due diligence into the acquisition assessment. Common findings include unrenewed VCI registrations, gaps in professional indemnity cover, undocumented animal custody arrangements, and unresolved past claims. Acquisition pricing and integration timelines should reflect the remediation effort required.

Platforms supporting integrated programme management for multi-site healthcare operators, with named portfolio insurer relationships, structured claims advocacy and regulatory compliance tracking, are increasingly available to brokers serving the pet care segment. Sarvada supports brokers in delivering this integrated capability for chain operator clients. Request Access to evaluate the platform fit for pet care chain engagements.

The Indian pet care segment is well positioned for continued strong growth through FY2026-27 and FY2027-28, with the implication that the underlying insurance underwriting question will only increase in importance. Brokers building practice depth in the segment now will hold competitive advantage as the segment scales toward broader corporate engagement and (over the longer term) potential public listing of leading chain operators.